What is an IND report

The phrase “IND safety reports” originates in FDA regulations 21 CFR 312 – Investigational New Drug Application. … The IND safety reports concern a product under study and such reports may not necessarily apply to events that occurred in the protocol conducted at JHM.

What is the purpose of an IND?

The stated purpose of an IND is “to ensure that subjects will not face undue risk of harm” in a clinical investigation that involves the use of a drug. Hence, to authorize a drug study in humans, the FDA requires sufficient information to assess the safety of the intended research study.

What is an IND annual report?

IND ANNUAL REPORT (IAR) Foreign studies involving the same drug that are not being conducted in the U. S. are not required to be submitted to the IND. This brief report concentrates on the safety of the drug and is known as the IND Annual Report (IAR).

What does it mean to file an IND?

IND Filing means an Investigational New Drug Application (as more fully defined in Title 21 CFR 312.22 and 312.23) and all amendments and supplements thereto filed with the FDA. Sample 2. Sample 3. IND Filing means the filing with a Regulatory Authority in a Major Market Country of an IND.

What happens after you file an IND?

Once an IND application is in effect, a drug manufacturer may ship the investigational new drug to the investigator(s) named in the application. An investigator may not administer an investigational new drug to human subjects until the IND application goes into effect.

How long does IND approval take?

The IND must make a decision on your application for review within 6 weeks. The decision period of 6 weeks always starts on the last day on which you are able to submit an application for review. Even if you submit the application for review earlier. This decision period can be extended by a maximum of 6 weeks.

What is an FDA IND?

An Investigational New Drug Application (IND) is a request from a clinical study sponsor to obtain authorization from the Food and Drug Administration (FDA) to administer an investigational drug or biological product to humans.

What is the purpose of preclinical testing?

The main goals of preclinical studies are to determine a starting, safe dose for first-in-human study and assess potential toxicity of the product, which typically include new medical devices, prescription drugs, and diagnostics.

What is included in an IND submission?

The IND application must contain information in three broad areas: Animal Pharmacology and Toxicology Studies – Preclinical data to permit an assessment as to whether the product is reasonably safe for initial testing in humans. Also included are any previous experience with the drug in humans (often foreign use).

How do I file an FDA IND?

Submission of an Emergency IND Initial submission of an IND for emergency use: During normal business hours (i.e., 8:00 AM – 4:30 PM, Monday to Friday), contact CBER’s Office of Communication, Outreach and Development of by phone at 240-402-8010 or 800-835-4709 ; or by email at: [email protected].

Article first time published on

When should I stop submitting DSUR?

The DSUR should be submitted no later than 60 calendar days from the DSUR data lock point. The data lock point of the DSUR should be based on the date of the sponsor’s first authorisation to conduct a clinical trial in any country. This date is termed the “Development International Birth Date” (DIBD).

How do I submit an annual report to the FDA?

The annual report must be accompanied by one copy of Form FDA-2252 (Transmittal of Annual Reports for Drugs and Biologics for Human Use) (21 CFR 601.70(b)). Submit two copies of the report to the CBER Document Control Center, HFM-99, 1401 Rockville Pike, Rockville, MD 20852- 1448.

Is DSUR annual report?

An annual report is comprised of a series of small documents, each of which describes changes to a specific category of data (see the table above). … In contrast, a DSUR is a single document that was originally developed in Europe and is accepted by both the FDA and the European Medicines Agency (EMA).

Does FDA approve IND?

An Investigational New Drug Application (IND) is a request for Food and Drug Administration (FDA) authorization to administer an investigational drug to humans. Such authorization must be secured prior to interstate shipment and administration of any new drug that is not the subject of an approved new drug application.

What information about the drug is the NDA expected to contain?

The documentation required in an NDA is supposed to tell “the drug’s whole story, including what happened during the clinical tests, what the ingredients of the drug are, the results of the animal studies, how the drug behaves in the body, and how it is manufactured, processed and packaged.” Currently, the FDA decision …

What is the difference between an IND and NDA?

The NDA is a formal request made by a Sponsor to market a new drug in the United States. … Data collected during the IND phase of the development program will become part of the NDA. However, the NDA is much more comprehensive than the IND and is expected to provide very detailed information about the drug.

What does IND approval mean?

IND Approval means the acceptance (or deemed acceptance) of the filing of an IND by the applicable Regulatory Authority. For purposes of clarity, acceptance (or deemed acceptance) of the filing of the foreign equivalent of an IND by the applicable Regulatory Authority in such country will be an IND Approval.

What is a commercial IND?

A commercial IND is one for which the sponsor (usually a corporate entity) intends to commercialize the product by eventually submitting a marketing application. … FDA may also designate an IND as commercial if it is clear that the sponsor intends for the product to be commercialized at a later date.

Does FDA reject IND?

The IND is the means through which the sponsor technically obtains this exemption from the FDA; however, its main purpose is to detail the data that provide documentation that it is indeed reasonable to proceed with certain human trials with the drug.

How long can I stay in the Netherlands after my residence permit expires?

With your Dutch residence permit you may stay in all Schengen countries up to 90 days in any 180 day period without a visa. You do not need a separate visa. Take your passport and residence permit with you. Your passport and residence permit must be valid for your entire trip.

Are IND filings public?

§ 312.130 Availability for public disclosure of data and information in an IND. (a) The existence of an investigational new drug application will not be disclosed by FDA unless it has previously been publicly disclosed or acknowledged.

Can I travel with residence endorsement sticker?

A residence permit or residence endorsement sticker is not a travel document. It does not allow for you to travel abroad or return to the Netherlands.

What are IND-enabling studies?

IND-enabling studies are conducted to evaluate the potential toxicity risks prior to human studies and to estimate starting doses for clinical trials. A complete IND-enabling program is dependent on the class of drug, route of administration, planned indication, and planned duration of treatment.

What are the benefits of the EU CTR?

improved collaboration, information-sharing and decision-making between and within Member States; increased transparency of information on clinical trials; highest standards of safety for all participants in EU clinical trials.

What is the target of a drug?

A drug target is a molecule in the body, usually a protein, that is intrinsically associated with a particular disease process and that could be addressed by a drug to produce a desired therapeutic effect.

What is the difference between preclinical and clinical trials?

While preclinical research answers basic questions about a drug’s safety, it is not a substitute for studies of ways the drug will interact with the human body. “Clinical research” refers to studies, or trials, that are done in people.

What animals are used in preclinical trials?

Mice, rabbits, guinea pigs and monkeys (non-human primates) are some of the animals used to evaluate potential candidates in preclinical in vivo experiments. The exact questions asked during preclinical research depend on the specific strategy being tested.

What happens after pre clinical trials?

After preclinical testing, researchers review their findings and decide whether the drug should be tested in people.

What form is used for IND?

Form FDA 3926 can be used by physicians when submitting requests for individual patient expanded access to investigational drugs, including in emergencies. This form is designed specifically for single patient IND requests. It can also be used for certain submissions to FDA after the initial application is filed.

Do you need a new IND for a new indication?

An IND is required when a drug is involved in a clinical investigation that is not exempt from the regulations. … There is no intent to report the investigation to FDA as a well-controlled study in support of a new indication and no intent to use it to support any other significant change in the labeling of the drug.

How often is a Psur submitted?

Before initial placing on the market, 6 monthly PSURs are submitted. Initial placing of the product on the European Union market triggers the start of the PSUR cycle of four 6 monthly reports followed by two yearly reports and thereafter three-yearly reports, unless other requirements have been laid down.